Profile: Alk Abello A/S (ALKb.CO)

ALKb.CO on Copenhagen Stock Exchange

716.00DKK
19 Sep 2014
Price Change (% chg)

kr.-17.00 (-2.32%)
Prev Close
kr.733.00
Open
kr.737.00
Day's High
kr.738.00
Day's Low
kr.690.00
Volume
11,727
Avg. Vol
8,838
52-wk High
kr.870.00
52-wk Low
kr.470.00

Search Stocks
Alk Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Company’s allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product offering comprises products for the management of anaphylaxis. Its allergy diagnostics product offering comprises allergen extracts for allergy testing, such as skin-prick tests. The Company operates worldwide through subsidiaries, production units and distributors in such countries as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States and China. In February 2014, its grass sublingual allergy immunotherapy tablet GRASTEK, which is licensed to Merck, was launched in Canada.

Company Address

Alk Abello A/S

Boege Alle 6-8
HOERSHOLM     2970
P: +4545.747576
F: +4545.748690

Search Stocks